CONTRAFECT Corp (CFRX) is a publicly traded company in the Unknown sector. Across all available filings, 20 corporate insiders have executed 33 transactions totaling $3.0M, demonstrating a bearish sentiment with -$2.1M in net insider flow. The most recent transaction on Dec 13, 2019 involved a purchase of 300,000 shares valued at $129.0K.
No significant insider buying has been recorded for CFRX in the recent period.
No significant insider selling has been recorded for CFRX in the recent period.
Based on recent SEC filings, insider sentiment for CFRX is bearish with an Insider Alignment Score of 14/100 and a net flow of -$2.1M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at CONTRAFECT Corp (CFRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 20 insiders are actively trading CFRX stock, having executed 33 transactions in the past 90 days. The most active insider is Fosun Pharmaceutical (group) Co., Ltd. Shanghai (Executive), who has made 1 transactions totaling $1.2M.
Get notified when executives and directors at CFRX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 13, 2019 | N. Low David | Executive | Purchase | 300,000 | $0.43 | $129.0K | |
| Dec 13, 2019 | Sucoff Cary | Executive | Purchase | 50,000 | $0.39 | $19.5K | |
| Dec 13, 2019 | Messinger Michael | Executive | Purchase | 5,000 | $0.37 | $1.9K | |
| Dec 4, 2018 | Pharmaceutical (group) Co., Ltd. Shanghai Fosun | Executive | Sale | 600,000 | $2.04 | $1.2M | Large |
| Dec 4, 2018 | Co., Ltd Fosun Industrial | Executive | Sale | 600,000 | $2.04 | $1.2M | Large |
| Jul 25, 2017 | C. Gilman Steven | Executive | Purchase | 800 | $1.24 | $992 | |
| Jul 25, 2017 | J. Barer Sol | Executive | Purchase | 40,000 | $1.24 | $49.6K | |
| Jul 25, 2017 | N. Low David | Executive | Purchase | 40,000 | $1.24 | $49.6K | |
| Jul 25, 2017 | J. Otto Michael | Executive | Purchase | 8,000 | $1.24 | $9.9K | |
| Jul 25, 2017 | Pomerantz Roger | Executive | Purchase | 800 | $1.24 | $992 | |
| Jul 25, 2017 | Ricciardi Lisa | Executive | Purchase | 9,600 | $1.24 | $11.9K | |
| Jul 25, 2017 | Sucoff Cary | Executive | Purchase | 12,000 | $1.24 | $14.9K | |
| Jul 25, 2017 | Bogdanos Natalie | Executive | Purchase | 800 | $1.24 | $992 | |
| Jul 25, 2017 | M. Cassino Cara | Executive | Purchase | 8,000 | $1.24 | $9.9K | |
| Jul 25, 2017 | Messinger Michael | Executive | Purchase | 800 | $1.24 | $992 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 9 | $2.5M | 73.6% |
Award(A) | 7 | $484.2K | 14.0% |
Purchase(P) | 17 | $426.4K | 12.4% |
Insider selling pressure at CONTRAFECT Corp has increased, with 20 insiders executing 33 transactions across all time. Total sales of $2.5M significantly outpace purchases of $426.4K, resulting in a net outflow of $2.1M. This selling activity appears largely discretionary, which may warrant closer attention from investors.